Results 161 to 170 of about 35,795 (270)

Differentiating the Clinical and Variant Spectrum of Hardikar Syndrome From Other MED12 ‐Related Developmental Disorders

open access: yesAmerican Journal of Medical Genetics Part A, Volume 200, Issue 7, Page 1619-1650, July 2026.
ABSTRACT The rare X‐linked female‐restricted Hardikar syndrome (HDKR, OMIM # 301068) is characterized by multiple congenital anomalies including orofacial clefts, gastrointestinal, genitourinary, and cardiac anomalies, but cognitive and neurobehavioral development is rarely impaired.
Tinne Warmoeskerken   +4 more
wiley   +1 more source

Ocrelizumab‐induced colitis: VigiBase disproportionality analysis, case reports and literature review

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 7, Page 2162-2170, July 2026.
Aims Ocrelizumab is a humanized anti‐CD20 monoclonal antibody used in multiple sclerosis. Since its commercialization, several cases of ocrelizumab‐induced colitis have been reported in the scientific literature. Methods To explore the potential association of ocrelizumab with colitis as an adverse drug reaction (ADR), we conducted a descriptive and ...
Audrey Fresse   +3 more
wiley   +1 more source

Challenges in Diagnosis and Management of Crohn's Disease in Bangladesh With Long Term Follow‐Up

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
Flow chart of patient journey from initial presentation (2021) till current clinical management (2025). ABSTRACT Crohn's disease (CD) is a chronic autoimmune inflammatory bowel disease (IBD) with significant diagnostic and therapeutic challenges. We reported a case of a 20‐year‐old Bangladeshi male with an 8‐month history of severe upper abdominal pain,
Imtiaz Abdullah   +7 more
wiley   +1 more source

On the Clinical Utility of Hybrid Endoscopy in Crohn's Disease

open access: yes
DEN Open, Volume 7, Issue 1, April 2027.
Anastasios Koulaouzidis   +2 more
wiley   +1 more source

Severe Neutropenia and Esophagitis Associated With Avelumab for Urothelial Carcinoma: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Bladder cancer prognosis varies with invasiveness, requiring treatments like surgery or chemotherapy. Immune checkpoint inhibitors, such as Avelumab, are standard for advanced cases but can cause side effects like neutropenia and esophagitis, as seen in a reported case during Avelumab maintenance therapy.
Takayuki Hirano   +10 more
wiley   +1 more source

Acute Cardiac Tamponade Following Enfortumab Vedotin Initiation in Metastatic Urothelial Carcinoma: Successful Rescue by Pericardial Fenestration

open access: yesIJU Case Reports, Volume 9, Issue 4, July 2026.
ABSTRACT Introduction Enfortumab vedotin is a Nectin‐4‐directed antibody–drug conjugate approved for metastatic urothelial carcinoma. Cardiac adverse events such as pericardial effusion or tamponade associated with enfortumab vedotin are extremely rare. Case Presentation A 50‐year‐old man with metastatic UC developed chest pain and dyspnea 3 days after
Hiroto Akamatsu   +7 more
wiley   +1 more source

Porcine gut loops to explore the impact of amino acids on the host-microbiota crosstalk in the ileum. [PDF]

open access: yesFront Microbiol
Renois F   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy